Schlafen4+髓源性抑制细胞来源的MiR130b促进上皮增殖并与胃癌前病变相关
该研究在幽门螺杆菌感染的SPEM小鼠模型中鉴定Slfn4+髓源性抑制细胞(MDSC)高表达MiR130b,MiR130b为其免疫抑制表型和促进化生所必需,并可促进胃上皮增殖和移植瘤生长;人胃癌组织及患者血清中MIR130b表达亦被检测。
要点
- Slfn4+ MDSC来源的MiR130b是维持其T细胞抑制表型和促进SPEM所必需的。
- MiR130b mimics可促进胃类器官上皮增殖并加速移植瘤生长。
- MiR130b与人类SLFN12L在胃癌中共定位,提示其临床相关性。
核心结论
- MiR130b在MDSC功能中起关键作用并支持化生性转化。
研究设计与样本
- 对幽门螺杆菌感染6个月后出现化生的SPEM小鼠胃组织分选SLFN4+与SLFN4-细胞,行mRNA RNA-Seq和microRNA NanoString nCounter转录组分析。
- 体外培养巯基乙酸盐诱导的腹腔髓系细胞并以IFNα诱导T细胞抑制表型、MIR130b和SLFN4表达。
- 在幽门螺杆菌感染小鼠体内用Invivofectamine敲低MiR130b。
- 以原发胃癌类器官建立移植瘤模型,并行ChIP和Western blot检测MIR130b对NF-κB p65的活化。
主要发现
- microRNA分析显示胃SLFN4+细胞中MiR130b升高。
- MIR130b在胃癌中与SLFN4的人同源物SLFN12L共定位。
- MiR130b是SLFN4+细胞表现T细胞抑制表型所必需,并促进幽门螺杆菌诱导的化生。
- MIR130b mimic处理胃类器官可诱导上皮细胞增殖并促进移植瘤生长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The myeloid differentiation factor Schlafen4 (Slfn4) marks a subset of myeloid-derived suppressor cells (MDSCs) in the stomach during Helicobacter-induced spasmolytic polypeptide-expressing metaplasia (SPEM). OBJECTIVE: To identify the gene products expressed by Slfn4+-MDSCs and to determine how they promote SPEM. DESIGN: We performed transcriptome analyses for both coding genes (mRNA by RNA-Seq) and non-coding genes (microRNAs using NanoString nCounter) using flow-sorted SLFN4+ and SLFN4- cells from Helicobacter-infected mice exhibiting metaplasia at 6 months postinfection. Thioglycollate-elicited myeloid cells from the peritoneum were cultured and treated with IFNα to induce the T cell suppressor phenotype, expression of MIR130b and SLFN4. MIR130b expression in human gastric tissue including gastric cancer and patient sera was determined by qPCR and in situ hybridisation. Knockdown of MiR130b in vivo in Helicobacter-infected mice was performed using Invivofectamine. Organoids from primary gastric cancers were used to generate xenografts. ChIP assay and Western blots were performed to demonstrate NFκb p65 activation by MIR130b. RESULTS: MicroRNA analysis identified an increase in MiR130b in gastric SLFN4+ cells. Moreover, MIR130b colocalised with SLFN12L, a human homologue of SLFN4, in gastric cancers. MiR130b was required for the T-cell suppressor phenotype exhibited by the SLFN4+ cells and promoted Helicobacter-induced metaplasia. Treating gastric organoids with the MIR130b mimic induced epithelial cell proliferation and promoted xenograft tumour growth. CONCLUSION: Taken together, MiR130b plays an essential role in MDSC function and supports metaplastic transformation.
引用
- Ding L, Li Q, Chakrabarti J, et al. MiR130b from Schlafen4+ MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer. Gut. 2020. PMID: 31980446. doi:10.1136/gutjnl-2019-318817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。